07:00 , Aug 4, 2008 |  BC Week In Review  |  Company News

Interleukin Genetics board of directors update

Interleukin Genetics Inc. (AMEX:ILI), Waltham, Mass.   Business: Diagnostic, Pharmacogenetics   Hired: Mary Chowning, director at Fincor Holdings Inc.; Glenn Armstrong, VP of corporate/business innovations at Alticor Inc.; and CEO Lewis Bender   Resigned: Dianne...
08:00 , Mar 3, 2008 |  BC Week In Review  |  Company News

Interleukin Genetics, Alticor Inc. deal

Interleukin Genetics Inc. (AMEX:ILI), Waltham, Mass.   Alticor Inc. , Ada, Mich.   Business: Diagnostic, Pharmacogenetics   Alticor’s Access Business Group LLC subsidiary will fund Interleukin to correlate SNPs in Asian populations to the risk...
07:00 , Apr 9, 2007 |  BC Week In Review  |  Company News

Interleukin Genetics, Alticor Inc. deal

ILI and Alticor's Access Business Group LLC subsidiary expanded their research collaboration to include a genetic tests to guide consumers' selection of skin care products, further development of tests for weight management and the risk...
07:00 , Jun 26, 2006 |  BC Week In Review  |  Company News

GeneOb Inc., Interleukin Genetics sales and marketing update

ILI received exclusive North American marketing rights to GeneOb's genetic test that predicts an individual's risk of weight gain and response to weight loss programs. ILI expects to launch the test next year with partner...
07:00 , Jun 19, 2006 |  BC Week In Review  |  Company News

Interleukin Genetics board of directors update

Interleukin Genetics Inc. (ILI), Waltham, Mass.   Business: Diagnostic, Pharmacogenetics   Appointed: Dianne Bennett, director of administration at Alticor Inc.; she replaces William Viveen Jr., who departed  ...
08:00 , Mar 7, 2005 |  BC Week In Review  |  Company News

Interleukin Genetics, Alticor Inc. deal

ILGN signed two research agreements with Alticor's Access Business Group LLC subsidiary. ILGN will conduct research to develop risk assessment tests for the Asian market, and to conduct exploratory research to identify new product opportunities....
07:00 , Sep 27, 2004 |  BC Week In Review  |  Company News

Interleukin Genetics board of directors update

Interleukin Genetics Inc. (ILGN), Waltham, Mass.   Business: Cardiovascular, Musculoskeletal, Autoimmune   Departed: Bert Crandell and Beto Guajardo   Appointed: William Viveen, VP of finance and corporate controller at Alticor Inc.  ...